0001209191-18-055121.txt : 20181016 0001209191-18-055121.hdr.sgml : 20181016 20181016162903 ACCESSION NUMBER: 0001209191-18-055121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181012 FILED AS OF DATE: 20181016 DATE AS OF CHANGE: 20181016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 181124701 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-12 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CL&AO Common Stock 2018-10-12 4 M 0 2125 90.29 A 41734 D Common Stock 2018-10-12 4 S 0 2125 177.20 D 39609 D Stock Option (Right to Buy) 90.29 2018-10-12 4 M 0 2125 0.00 D 2026-07-11 Common Stock 2125 14875 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 7/12/2016. /s/ Stephen Migausky, Attorney-in-Fact 2018-10-16